drugset / Trial / NCT00289848

MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)

NCT00289848

Phase 3 Completed 530 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a clinical study to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.

Timeline

Start
2006-03
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 100 mg Oral